Rafael Holdings is focused on developing novel cancer and immune therapies. The company is a significant investor in two clinical stage oncology companies, Cornerstone Pharmaceuticals, Inc., and LipoMedix Pharmaceuticals Ltd., and is seeking opportunities to invest, acquire or in-license additional therapeutic assets which address high unmet medical needs.

Rafael Holdings invests in novel cancer therapeutics that have the potential to improve and extend the lives of patients

Rafael Holdings invests in novel cancer therapeutics that have the potential to improve and extend the lives of patients.

News

Press Release
News Coverage